캐나다 - 영어 - Health Canada

pfizer canada ulc - gemcitabine (gemcitabine hydrochloride) - solution - 38mg - gemcitabine (gemcitabine hydrochloride) 38mg - antineoplastic agents

캐나다 - 영어 - Health Canada

generic medical partners inc - gemcitabine (gemcitabine hydrochloride) - powder for solution - 200mg - gemcitabine (gemcitabine hydrochloride) 200mg - antineoplastic agents

캐나다 - 영어 - Health Canada

generic medical partners inc - gemcitabine (gemcitabine hydrochloride) - powder for solution - 1g - gemcitabine (gemcitabine hydrochloride) 1g - antineoplastic agents

캐나다 - 영어 - Health Canada

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 200mg - gemcitabine (gemcitabine hydrochloride) 200mg - antineoplastic agents

캐나다 - 영어 - Health Canada

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 1g - gemcitabine (gemcitabine hydrochloride) 1g - antineoplastic agents

캐나다 - 영어 - Health Canada

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 2g - gemcitabine (gemcitabine hydrochloride) 2g - antineoplastic agents

캐나다 - 영어 - Health Canada

dr reddy's laboratories ltd - gemcitabine (gemcitabine hydrochloride) - powder - 200mg - gemcitabine (gemcitabine hydrochloride) 200mg - antineoplastic agents

캐나다 - 영어 - Health Canada

dr reddy's laboratories ltd - gemcitabine (gemcitabine hydrochloride) - powder - 1g - gemcitabine (gemcitabine hydrochloride) 1g - antineoplastic agents

캐나다 - 영어 - Health Canada

dr reddy's laboratories ltd - gemcitabine (gemcitabine hydrochloride) - powder - 2g - gemcitabine (gemcitabine hydrochloride) 2g - antineoplastic agents

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gemcitabine hydrochloride 2277mg equivalent to 2000 mg gemcitabine base;  ;   - powder for injection - 2g/vial - active: gemcitabine hydrochloride 2277mg equivalent to 2000 mg gemcitabine base     excipient: hydrochloric acid mannitol sodium acetate trihydrate sodium hydroxide - non-small cell lung cancer: gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.